News 2010 BIO: Celebrating Regional Innovation and Biotech’s Future Illinois Governor Pat Quinn visits the Chicago Innovation Pipeline booth at the 2010 BIO Convention held at McCormick Place. The pipeline, developed by UChicagoTech, is a collection of technologies available...
News Maker Community Comes Together to 3D Print Personal Protective Equipment When the coronavirus pandemic and state-wide stay-at-home orders in mid-March forced the Polsky Fabrication Lab to temporarily close its doors to the public, Polsky assistant director, Elizabeth Koprucki, was in...
News AbbVie Joins UChicago to Talk Oncology Research, Ongoing Collaboration, and Opportunities for Expansion The annual UChicago-AbbVie Research Symposium in August celebrated another successful year of the strategic partnership – bringing together academia and industry to exchange new ideas and drive innovation. The event...
News AbbVie and UChicago Extend Collaboration to Support Preclinical Oncology Research The University of Chicago and AbbVie have announced an extended collaboration agreement through 2025 to support preclinical oncology research. To date, the collaboration has led to novel insights related to...
News Innovation through Academic-Industry Partnerships in Clinical Trials The University of Chicago Medicine performs more clinical trials than any other hospital in Illinois – translating ground-breaking innovations into life-changing therapeutics for patients in need. Join UChicago Medicine on...
News ‘You Need a Village’: Clinical Trial Leaders Discuss Collaborations, COVID, and Widening the Lens Experts came together on Clinical Trials Day to discuss why early and frequent discussions among all stakeholders are necessary, how COVID forced the industry to think “more clearly and sharply...
News AbbVie, University of Chicago Symposium to Showcase Latest Oncology Research Efforts The UChicago-AbbVie Research Symposium celebrates another successful year of strategic partnership, showcasing select innovative research efforts in oncology. Taking place Friday, August 19, 2022, the symposium aims to stimulate engagement...
Technology Diagnostic For Predicting Hospital-Acquired Infections And Identifying Causative Organisms The technology is a fecal microbiome metabolite profile that can predict hospital-acquired infections and identify the causative organisms. This method efficiently measures specific chemical metabolites produced by bacteria in the…
Technology Defined Live Biotherapeutic Compositions That Restore Depleted Gut Metabolites To Improve Outcomes In Liver Disease Patients Patients with advanced liver disease, transplant recipients, and other critically ill populations frequently experience profound microbiome dysbiosis due to antibiotics and hospitalization. This dysbiosis is characterized by loss of microbial…
Technology Microbiome-Based Stratification and Lactulose Therapy for Infection Prevention in Advanced Liver Disease Improved survival and reduced systemic infections in advanced liver disease patients by expanding gut Bifidobacteria through lactulose administration, leveraging metabolomic profiling to stratify candidates for targeted microbiome-based therapeutics The Unmet…